Androgen Replacement as Treatment for Hormone Refractory Prostate Cancer

Abstract

This grant funded planning activities for initiation of a randomized phase II trial to study androgen replacement in early phase hormone refractory prostate cancer. A grant was completed and submitted to the DOD. A clinical protocol was completed and submitted to the lRB. All regulatory and collaborative agreements were completed except for finalization of drug delivery process with the pharmaceutical collaborator when it was announced that the clinical trial grant was not funded.

Open PDF

Document Details

Document Type
Technical Report
Publication Date
Aug 01, 2005
Accession Number
ADA442980

Entities

People

  • Walter M. Stadler

Organizations

  • University of Chicago

Tags

DTIC Thesaurus Topics

  • Agreements
  • Androgens
  • Biomedical Research
  • Clinical Trials
  • Department Of Defense
  • Electronic Mail
  • Hormones
  • Information Operations
  • Neoplasms
  • Prostate
  • Prostate Cancer
  • Quality Of Life

Fields of Study

  • Medicine

Readers

  • Clinical Trial Research.
  • Women's Health and Cancer Risk Research: African American Women and Pregnancy Outcomes.